Tenaya Therapeutics Inc (TNYA)
4.54
+0.23
(+5.34%)
USD |
NASDAQ |
Apr 29, 16:00
4.55
+0.01
(+0.22%)
After-Hours: 20:00
Tenaya Therapeutics Free Cash Flow: -103.31M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -103.31M |
| September 30, 2023 | -104.47M |
| June 30, 2023 | -112.44M |
| March 31, 2023 | -118.62M |
| December 31, 2022 | -125.05M |
| September 30, 2022 | -130.48M |
| June 30, 2022 | -120.52M |
| Date | Value |
|---|---|
| March 31, 2022 | -103.17M |
| December 31, 2021 | -85.93M |
| September 30, 2021 | -75.61M |
| June 30, 2021 | -63.64M |
| March 31, 2021 | -56.65M |
| December 31, 2020 | -45.21M |
Free Cash Flow Range, Past 5 Years
-130.48M
Minimum
Sep 2022
-45.21M
Maximum
Dec 2020
-95.78M
Average
-103.31M
Median
Dec 2023
Free Cash Flow Benchmarks
| Adverum Biotechnologies Inc | -91.71M |
| Solid Biosciences Inc | -95.70M |
| Dyne Therapeutics Inc | -188.89M |
| Sana Biotechnology Inc | -273.61M |
| Prime Medicine Inc | -174.14M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.92M |
| Cash from Investing (Quarterly) | -14.92M |
| Cash from Financing (Quarterly) | 0.371M |
| Free Cash Flow Per Share (Quarterly) | -0.2999 |
| Free Cash Flow Yield | -30.87% |